Navigation Links
Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time
Date:7/28/2011

2 40% 9% PENTASA 130.3 118.8 10% 6% RESOLOR 2.5 - n/a <1% 319.1 252.0 27% 16% Regenerative Medicine DERMAGRAFT 2.0 - n/a <1% 2.0 - n/a <1% General products FOSRENOL 86.5 92.1 -6% 4% XAGRID 45.9 45.0 2% 2% CARBATROL 33.3 43.1 -23% 2% 165.7 180.2 -8% 8% Other product sales 47.7 54.8 -13% 2% Total SP product sales 1,292.8 1,092.6 18% 64% HGT ELAPRASE 231.3 200.6 15% 11% REPLAGAL 225.3 149.9 50% 11% VPRIV 122.3 34.5 254% 6% FIRAZYR 10.9 4.8 127% <1% Total HGT product sales 589.8 389.8 51% 29% Total product sales 1,882.6 1,482.4 27% 93% Royalties: 3TC and ZEFFIX 46.8 74.7 -37% 2% ADDERALL XR 43.7 68.3 -36% 2% FOSRENOL 20.5 11.1 85% 1% Other 26.0 23.9 9% 1% Total royalties 137.0 178.0 -23% 6% Other revenues 15.5 5.1 204% 1% Total Revenues 2,035.1 1,665.5 22% 100%

Unaudited results for the three months to June 30, 2011

Non GAAP reconciliation

US GAAP Adjustments Acquisitions Divestments, Amortization & reorganizations & asset integration & discontinued 3 months to, June 30, impairments activities operations 2011 (a) (b) (c) $M $M $M $M Total revenues 1,062.9 - - - Costs and expenses: Cost of product sales 143.7 - - (2.8) Research and development 176.9 - - - Selling, general and administrative 440.3 (36.7) - - Loss on sale of product rights 2.2 - - (2.2) Reorganization costs 7.5 - - (7.5) Integration and acquisition costs 9.0 - (9.0) - Depreciation - - - - Total operating expenses 779.6 (36.7) (9.0) (12.5) Operating income 283.3 36.7 9.0 12.5 Interest income 0.6 - - - Interest expense (9.9) - - - Total other expense, net (9.3) - - - Income before income taxes and equity in earnings of equity method investees 274.0 36.7 9.0 12.5 Income taxes (69.7) (3.9) (1.1) (2.4) Equity in earnings of equity method investees, net of tax 1.2 - - - Net income 205.5 32.8 7.9 10.1 Impact of convertible debt, net of tax 8.4 - - - Numerator for diluted EPS 213.9 32.8 7.9 10.1 Weighted average number of shares (millions) - diluted 595.
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

Related biology technology :

1. Neogen Reports 27% Increase in Quarterly Net Income
2. Sigma-Aldrich (Nasdaq: SIAL) Reports Q4 and Full Year 2010 Diluted EPS of $0.76 and $3.12, Respectively. Q4 and Full Year 2010 Adjusted Diluted EPS Were $0.83 and $3.31, Respectively. Q4 Sales Set New Quarterly High. 2011 Diluted EPS Expected to be
3. Microbix Has Best-Ever Quarterly Sales
4. Amylin Pharmaceuticals Announces Third Quarter Product Revenues; Quarterly Update Conference Call Canceled
5. China-Biotics, Inc. Reports Record Quarterly and Annual Revenue Growth for Fiscal Year 2010
6. Shires Replenished Portfolio Drives Excellent Quarterly Performance
7. Quest Diagnostics Declares Quarterly Cash Dividend
8. Sigma-Aldrich (Nasdaq: SIAL) Declares Quarterly Dividend
9. Schering-Plough Declares Quarterly Dividends on Common Shares and Mandatory Convertible Preferred Stock
10. Abbott Declares 343rd Consecutive Quarterly Dividend
11. Sigma-Aldrich (Nasdaq: SIAL) Declares Quarterly Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... Research and Markets ... of the "Oxidative Stress Assay Market ... (Indirect, Enzyme-based, Reactive Oxygen Species (ROS)-based), Technology ... Global Forecast to 2020" report to ... , The global oxidative stress ...
(Date:6/1/2015)... 1, 2015 GenomeDx Biosciences today ... platform, successfully classified various subtypes of bladder ... certain biomarkers, including one type associated with ... genomic signature has potential as a tool ... in patients with muscle-invasive bladder cancers (MIBC). ...
(Date:6/1/2015)... June 1, 2015  Novartis is highlighting data ... CTL019, an investigational chimeric antigen receptor (CAR) T ... treatment of specific types of hard-to-treat non-Hodgkin lymphoma. ... University of Pennsylvania,s Perelman School of Medicine (Penn) ... large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) ...
(Date:6/1/2015)... Regis Technologies, Inc. is a ... stationary phases (CSPs) for analytical and preparative chromatography ... presenting solutions for new clients, Regis implemented a ... addition to its core expertise in chiral chromatography ... tackle projects for the scale clients need–from milligram ...
Breaking Biology Technology:Oxidative Stress Assay Market 2015 - Global Forecast to 2020 2GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 2GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 3GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 4Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 2Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 3Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 4Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 5Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 6Regis Technologies Offers Chiral Chromatography Service 2Regis Technologies Offers Chiral Chromatography Service 3
... NEW YORK, Nov. 29, 2011  Roche (SIX: RO, ROG; OTCQX: ... announced today a licensing agreement for PTC,s Spinal Muscular ... that causes muscle weakness. One in every 10,000 children ... no effective treatment. PTC Therapeutics, programme ...
... CHICAGO, Nov. 29, 2011 Sundberg , a leading ... appliance and HVAC parts, is kicking ... the opening of a new headquarters facility and two state-of-the-art ... in the development of two world-class, logistically centric warehouses: a ...
...   Bacterin International Holdings, Inc. (NYSE Amex: ... revolutionary bone graft material and antimicrobial coatings for medical ... for distribution in the U.S. and Canada of Jeil,s ... of orthopedic implants used in craniomaxillofacial procedures, including trauma ...
Cached Biology Technology:Roche Signs Agreement with PTC Therapeutics to Advance Treatment for Spinal Muscular Atrophy (SMA) 2Roche Signs Agreement with PTC Therapeutics to Advance Treatment for Spinal Muscular Atrophy (SMA) 3Roche Signs Agreement with PTC Therapeutics to Advance Treatment for Spinal Muscular Atrophy (SMA) 4Sundberg Kicks Off National Expansion With Openings of New Headquarters, Logistically Centric Mega Warehouses 2Bacterin Signs Distribution Agreement with Jeil for 'LeForte Craniomaxillofacial System' 2Bacterin Signs Distribution Agreement with Jeil for 'LeForte Craniomaxillofacial System' 3Bacterin Signs Distribution Agreement with Jeil for 'LeForte Craniomaxillofacial System' 4
(Date:5/11/2015)... JOSE, Calif. , May 11, 2015 /PRNewswire/ ... developer of human interface solutions, today announced the ... Vice President and Chief Financial Officer, reporting to ... Ali replaces Synaptics, current Chief Financial Officer, ... December 2014. Mr. Ali brings ...
(Date:5/10/2015)... , May 11, 2015 Fingerprint Cards ... FPC1025 and FPC1155 from the distributor World Peace Industrial Group ... distributors in Asia . Deliveries are planned ... be used by smartphone manufacturers in China ... the communicated revenue guidance of + 1 000 MSEK for 2015. ...
(Date:5/6/2015)... TEL AVIV, Israel , May 6, 2015 /PRNewswire/ ... the world,s most established helmet producer, announced today that ... LifeBEAM Smart Helmet, the world,s first bio-sensing cycling helmet ... will be released in two new colors in order ... demand for the product. In addition, LifeBEAM and Lazer ...
Breaking Biology News(10 mins):Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 235 Million 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3
... University of Chicago show how the bacteria that cause the ... slightly altering one of the microbe's tools, the researchers produced ... Both papers -- one published online July 28 in Science ... Immunity -- focus on aspects of the type-III pathway, a ...
... understanding of exactly how the brain controls breathing is ... that breathing is an automatic rhythmic process that persists ... but the question that has intrigued many scientists for ... fail safe vital rhythm throughout life? , Experimental Physiology ...
... Services University of the Health Sciences (USU), the ... Cancer Institute (NCI) have made a major breakthrough ... could be engineered for use as bioweapons. The ... and Hendra viruses--naturally occurring and highly pathogenic paramyxoviruses ...
Cached Biology News:Studies reveal how plague disables immune system, and how to exploit the process to make a vaccine 2Studies reveal how plague disables immune system, and how to exploit the process to make a vaccine 3Studies reveal how plague disables immune system, and how to exploit the process to make a vaccine 4How exactly does the brain control breathing? 2Discovery could be key to bioterrorism defense 2Discovery could be key to bioterrorism defense 3
...
... cDNA normalization is essential for hunting ... high-throughput approaches, such as EST sequencing ... Evrogen TRIMMER-DIRECT kit is developed for ... sequences and intended for directional cloning. ...
Peptide-affinity Purified Polyclonal Antibody to ICEBERG Peptide with sequence EEDPQLASKMGLH, from C Terminus of the protein sequence according to NP_067546...
Purified anti-Fanconi anemia D2-Phosphorylated (Ser222)...
Biology Products: